Moderna's COVID-19 vaccine shows promise against Delta variant in lab study

REUTERS Moderna Inc's (MRNA.O) COVID-19 vaccine showed promise against the Delta variant fi...

Mix-and-match approach boosts immune response of AstraZeneca shot, study finds

REUTERS

Oxford vaccine produces strong immune response from booster shot - study

Spanking can worsen a child's behavior and do real harm, study finds

Physical punishment does not appear to improve a child's positive behavior or social competence over time, according to a review of 69 studies from the US, Canada, China, Colombia, Greece, Japan, Switzerland, Turkey and the United Kingdom.

Dual-antibody drugs effective against COVID-19 variants in animal study

COVID-19 therapies made from a cocktail of two types of antibodies were effective against a wide range of variants of the coronavirus in a mice and hamster study, the Washington University School of Medicine in St. Louis reported on Monday. Antibo..

Prior COVID-19 infection reduces infection risk for 10 months -study

Previous COVID-19 infection substantially reduces the risk of a new infection for up to 10 months afterwards, according to a study of care home residents and staff by University College London (UCL) scientists. The study, published in The Lancet H..

Study finds probable link between Pfizer vaccine and myocarditis cases

Study finds a probable link between Pfizer's COVID-19 vaccine and a small number of heart inflammation cases observed mainly in young men Israel’s Health Ministry said on Tuesday it had found the small number of heart inflammation cases ..

South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective

The coronavirus variant discovered in South Africa can break through the protection provided by Pfizer Inc and BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found. However, the variant's prevalence in Israel is..

South African variant can 'break through' Pfizer vaccine, study says

The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not ..